|
Caremast vet
|
600 mg
|
V/DCP/16/0004
|
Vetcare Oy, Somija
|
QJ51CE09
|
lactating cows
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/16/0004-01 |
600 mg |
3 |
Polipropilēna pilnšļirce, 1 deva |
-
|
| V/DCP/16/0004-02 |
600 mg |
5 |
Polipropilēna pilnšļirce, 1 deva |
-
|
| V/DCP/16/0004-03 |
600 mg |
20 |
Polipropilēna pilnšļirce, 1 deva |
-
|
| V/DCP/16/0004-04 |
600 mg |
40 |
Polipropilēna pilnšļirce, 1 deva |
-
|
| V/DCP/16/0004-05 |
600 mg |
100 |
Polipropilēna pilnšļirce, 1 deva |
-
|
|
|
Cevac Salmovac
|
-
|
V/MRP/21/0074
|
Ceva Sante Animale', Francija
|
QI01AE01
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for use in drinking water
|
| International name (active substance): |
Salmonella enterica, subsp. enterica, serovar Enteritidis, strain 441/014 (adenine and histidine auxotrophic), Live
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija;IDT Biologika GmbH, Vācija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (22-Aug-2025)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (22-Aug-2025)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (19-Jan-2026)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/21/0074-01 |
|
1 |
Stikla flakons, 1000 deva |
-
|
| V/MRP/21/0074-02 |
|
10 |
Stikla flakons, 1000 deva |
-
|
| V/MRP/21/0074-03 |
|
1 |
Stikla flakons, 5000 deva |
[PDF]
[PDF]
[DOCX]
|
| V/MRP/21/0074-04 |
|
12 |
Stikla flakons, 5000 deva |
-
|
| V/MRP/21/0074-05 |
|
1 |
Stikla flakons, 2500 deva |
-
|
| V/MRP/21/0074-06 |
|
10 |
Stikla flakons, 2500 deva |
-
|
|
|
Biocan M
|
-
|
V/NRP/97/0594
|
Bioveta, a.s., Čehija
|
QI06AQ02
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/97/0594-01 |
|
10 |
Flakons, 1 ml |
-
|
| V/NRP/97/0594-03 |
|
2 |
Flakons, 1 ml |
-
|
| V/NRP/97/0594-05 |
|
20 |
Flakons, 1 ml |
-
|
| V/NRP/97/0594-06 |
|
50 |
Flakons, 1 ml |
-
|
| V/NRP/97/0594-07 |
|
100 |
Flakons, 1 ml |
-
|
|
|
Biocan DHPPi
|
-
|
V/NRP/01/1332
|
Bioveta, a.s., Čehija
|
QI07AD04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Attenuated canine distemper virus,Attenuated canine parainfluenza virus,Attenuated canine contagious laryngotracheitis virus,Live attenuated Canine Parvovirus (CPV)
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
27-May-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (24-Mar-2026)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1332-01 |
|
5 |
Flakons, 1 ml |
-
|
| V/NRP/01/1332-02 |
|
10 |
Flakons, 1 ml |
-
|
| V/NRP/01/1332-03 |
|
50 |
Flakons, 1 ml |
-
|
|
|
TRICHOBEN
|
-
|
V/NRP/20/0033
|
Bioveta, ,a.s., Čehija
|
QI02AP01
|
cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/20/0033-01 |
|
5 |
Stikla flakons, 10 ml;Pudele (šķīdinātājs), 10 ml |
-
|
| V/NRP/20/0033-02 |
|
1 |
Stikla flakons, 10 ml;Pudele (šķīdinātājs), 40 ml |
-
|
| V/NRP/20/0033-03 |
|
1 |
Stikla flakons, 10 ml;Pudele (šķīdinātājs), 80 ml |
-
|
|
|
Ketoliv
|
100 mg/ml
|
V/DCP/26/0001
|
P.H. Farmaceutici S.r.l., Itālija
|
QM01AE03
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/26/0001-01 |
|
1 |
Stikla flakons, 100 ml |
-
|
|
|
Continence
|
40 mg/ml
|
V/SRP/26/0004
|
Fatro S.p.A., Itālija
|
QG04BX91
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/SRP/26/0004-01 |
|
1 |
ABPE pudele, 50 ml |
-
|
| V/SRP/26/0004-02 |
|
1 |
ABPE pudele, 100 ml |
-
|
|
|
Miziverm 12.5/125 mg
|
-
|
V/DCP/26/0006
|
Bioveta a.s., Čehija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/26/0006-01 |
|
2 |
PET/ALU/ZBPE maisiņš, 1 tablete |
-
|
| V/DCP/26/0006-02 |
|
50 |
PET/ALU/ZBPE maisiņš, 1 tablete |
-
|
|
|
Miziverm 2.5/25 mg
|
-
|
V/DCP/26/0005
|
Bioveta a.s., Čehija
|
QP54AB51
|
small dogs; puppies
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/26/0005-01 |
|
2 |
PET/ALU/ZBPE maisiņš, 1 tablete |
-
|
| V/DCP/26/0005-02 |
|
50 |
PET/ALU/ZBPE maisiņš, 1 tablete |
-
|
|
|
Dexdormostart
|
0.5 mg/ml
|
V/DCP/23/0063
|
Alfasan Nederland BV, Nīderlande
|
QN05CM18
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0063-01 |
|
1 |
Stikla flakons, 5 ml |
-
|
| V/DCP/23/0063-02 |
|
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/23/0063-03 |
|
1 |
Stikla flakons, 20 ml |
-
|
|
|
Doxatib
|
500 mg/g
|
V/DCP/16/0030
|
KRKA, d.d., Novo mesto, Slovēnija
|
QJ01AA02
|
pigs; chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/16/0030-01 |
500 mg/g |
1 |
PET/AL/PE maisiņš, 100 g |
-
|
| V/DCP/16/0030-02 |
500 mg/g |
1 |
PET/AL/PE maisiņš, 1 kg |
-
|
| V/DCP/16/0030-03 |
500 mg/g |
1 |
PET/AL/PE maisiņš, 5 kg |
-
|
| V/DCP/16/0030-04 |
500 mg/g |
1 |
PET/Al/PET/PE maisiņš, 100 g |
-
|
| V/DCP/16/0030-05 |
500 mg/g |
1 |
PET/Al/PET/PE maisiņš, 1 kg |
-
|
| V/DCP/16/0030-06 |
500 mg/g |
1 |
PET/Al/PET/PE maisiņš, 5 kg |
-
|
|
|
Frontline Tri-Act
|
-
|
V/MRP/18/0057
|
Boehringer Ingelheim Animal Health France SCS , Francija
|
QP53AX65
|
dogs 2-5 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/18/0057-01 |
|
1 |
Pipete, 0,5 ml |
-
|
| V/MRP/18/0057-02 |
|
3 |
Pipete, 0,5 ml |
-
|
| V/MRP/18/0057-03 |
|
6 |
Pipete, 0,5 ml |
-
|
|
|
Frontline Tri-Act
|
-
|
V/MRP/18/0058
|
Boehringer Ingelheim Animal Health France SCS , Francija
|
QP53AX65
|
dogs 5-10 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/18/0058-01 |
|
1 |
Pipete, 1 ml |
-
|
| V/MRP/18/0058-02 |
|
3 |
Pipete, 1 ml |
-
|
| V/MRP/18/0058-03 |
|
6 |
Pipete, 1 ml |
-
|
|
|
Frontline Tri-Act
|
-
|
V/MRP/18/0059
|
Boehringer Ingelheim Animal Health France SCS , Francija
|
QP53AX65
|
dogs 10-20 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/18/0059-01 |
|
1 |
Pipete, 2 ml |
-
|
| V/MRP/18/0059-02 |
|
3 |
Pipete, 2 ml |
-
|
| V/MRP/18/0059-03 |
|
6 |
Pipete, 2 ml |
-
|
|
|
Frontline Tri-Act
|
-
|
V/MRP/18/0060
|
Boehringer Ingelheim Animal Health France SCS , Francija
|
QP53AX65
|
dogs 20-40 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/18/0060-01 |
|
1 |
Pipete, 4 ml |
-
|
| V/MRP/18/0060-02 |
|
3 |
Pipete, 4 ml |
-
|
| V/MRP/18/0060-03 |
|
6 |
Pipete, 4 ml |
-
|
|
|
Frontline Tri-Act
|
-
|
V/MRP/18/0061
|
Boehringer Ingelheim Animal Health France SCS , Francija
|
QP53AX65
|
dogs 40 – 60 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/18/0061-01 |
|
1 |
Pipete, 6 ml |
-
|
| V/MRP/18/0061-02 |
|
3 |
Pipete, 6 ml |
-
|
| V/MRP/18/0061-03 |
|
6 |
Pipete, 6 ml |
-
|
|
|
Pergocoat
|
0.5 mg
|
V/DCP/21/0054
|
Alfasan Nederland BV, Nīderlande
|
QN04BC02
|
horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0054-01 |
|
1 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-02 |
|
3 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-03 |
|
6 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-04 |
|
9 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-05 |
|
10 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-06 |
|
12 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-07 |
|
16 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-08 |
|
24 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-09 |
|
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-10 |
|
3 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-11 |
|
6 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-12 |
|
9 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-13 |
|
10 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-14 |
|
12 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-15 |
|
16 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0054-16 |
|
24 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
|
Pergocoat
|
1 mg
|
V/DCP/21/0055
|
Alfasan Nederland BV, Nīderlande
|
QN04BC02
|
horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0055-01 |
|
1 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-02 |
|
3 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-03 |
|
6 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-04 |
|
9 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-05 |
|
10 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-06 |
|
12 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-07 |
|
16 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-08 |
|
24 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-09 |
|
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-10 |
|
3 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-11 |
|
6 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-12 |
|
9 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-13 |
|
10 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-14 |
|
12 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-15 |
|
16 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0055-16 |
|
24 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
|
Pergocoat
|
2 mg
|
V/DCP/21/0056
|
Alfasan Nederland BV, Nīderlande
|
QN04BC02
|
horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0056-01 |
|
1 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-02 |
|
3 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-03 |
|
6 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-04 |
|
9 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-05 |
|
10 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-06 |
|
12 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-07 |
|
16 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-08 |
|
24 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-09 |
|
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-10 |
|
3 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-11 |
|
6 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-12 |
|
9 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-13 |
|
10 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-14 |
|
12 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-15 |
|
16 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/21/0056-16 |
|
24 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
|
STENOROL CRYPTO
|
0.50 mg/ml
|
V/DCP/20/0042
|
Huvepharma NV, Beļģija
|
QP51AX08
|
cattle (calf)
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/20/0042-01 |
0,5 mg/ml |
1 |
ABPE pudele, 500 ml |
-
|
| V/DCP/20/0042-02 |
0,5 mg/ml |
1 |
ABPE pudele, 1 l |
-
|
|